Stay updated on Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.

Latest updates to the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page
- CheckyesterdayChange DetectedThe history now notes that recruitment is closed ('No longer looking for participants') and the revision tag has been updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.4%

- Check8 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 in the page history, signaling a new revision of the record. It represents a metadata version change rather than altering study data or content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s revision tag was updated from v3.5.3 to v3.5.4, indicating a new release version in the history. This update does not change the underlying study content.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the trial record content.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded Revision: v3.5.2 and deleted Revision: v3.5.0 from the version history.SummaryDifference0.2%

- Check65 days agoChange DetectedVisual/UI adjustments to the Record History page without any changes to study data or statuses.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.